Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|17|2667-2688

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.17, 2012-06, pp. : 2667-2688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases

By  

Current Medicinal Chemistry, Vol. 10, Iss. 12, 2003-06 ,pp. : 1005-1019

Bentham Science Publishers

Access to resources Recommend Favorite

Production and Application of Copper Radiopharmaceuticals

By  

Current Radiopharmaceuticals, Vol. 2, Iss. 2, 2009-04 ,pp. : 92-101

Bentham Science Publishers

Access to resources Recommend Favorite

The Design and Development of Deferiprone (L1) and Other Iron Chelators for Clinical Use: Targeting Methods and Application Prospects

By  

Current Medicinal Chemistry, Vol. 11, Iss. 16, 2004-08 ,pp. : 2161-2183

Bentham Science Publishers

Access to resources Recommend Favorite

Development and Clinical Application of Peptide-Based Radiopharmaceuticals

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2951-2963

Bentham Science Publishers

Access to resources Recommend Favorite

99mTc and 111In-Labeling of Small Biomolecules: Bifunctional Chelators and Related Coordination Chemistry

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 11, 2010-08 ,pp. : 1113-1134

Bentham Science Publishers

Access to resources Recommend Favorite